Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Type
2.4. Snippet by Product Type
2.5. Snippet by Specimen
2.6. Snippet by Application
2.7. Snippet by End-User
2.8. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increasing Innovation and Launches of Advanced Immunoassay Instruments
3.1.1.2. Rising Prevalence of Chronic & Infectious Diseases
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. The High Cost of Instruments & Reagents
3.1.2.2. Complex Assay Procedures
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Increasing Research and Development
3.1.3.2. XX
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. Immunoassay Market, By Type
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
5.1.2. Market Attractiveness Index, By Type
5.2. ELISA*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Radioimmunoassay (RIA)
5.4. Fluorescence Immunoassays (FIA)
5.5. Chemiluminescence Immunoassays (CLIA)
5.6. Rapid Assays
5.7. Others
6. Immunoassay Market, By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Reagents & kits*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. ELISA Reagents & Kits
6.2.4. Rapid Test Reagents & Kits
6.2.5. ELISPOT Reagents & Kits
6.2.6. Western Blot Reagents & Kits
6.2.7. Others
6.3. Analyzers
6.3.1. Open-ended Systems
6.3.2. Closed-ended Systems
6.4. Software & Services
7. Immunoassay Market, By Specimen
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
7.1.2. Market Attractiveness Index, By Specimen
7.2. Blood*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Saliva
7.4. Urine
7.5. Other
8. Immunoassay Market, By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Therapeutic Drug Monitoring*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Drug Discovery
8.4. Disease Diagnosis
8.4.1. Infectious Disease
8.4.2. Cancer
8.4.3. Endocrinology
8.4.4. Autoimmune Disorders
8.4.5. Cardiology
8.4.6. Hematology
8.4.7. Others
8.5. Other
9. Immunoassay Market, By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Banks
9.4. Clinical Laboratories
9.5. Pharmaceutical and Biotech Companies
9.6. Academic Research Centers
9.7. Others
10. Immunoassay Market, By Regional Market Analysis and Growth Opportunities
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. U.K.
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. Brazil
10.4.8.2. Argentina
10.4.8.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. China
10.5.8.2. India
10.5.8.3. Japan
10.5.8.4. South Korea
10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape and Market Positioning
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. Company Profiles
12.1. Beckman Coulter, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.2.3. Historic and Forecasted Product Sales
12.1.2.4. Product Sales Volume
12.1.3. Financial Overview
12.1.3.1. Company Revenue
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals, etc.
12.1.5. SWOT Analysis
12.2. F. Hoffmann-La Roche Ltd
12.3. Siemens Healthineers AG
12.4. BioM?rieux SA
12.5. Bio-Rad Laboratories, Inc
12.6. Abbott
12.7. DiaSorin S.p.A.
12.8. BD
12.9. Thermo Fisher Scientific Inc.
12.10. Merck KGaA
LIST NOT EXHAUSTIVE
13. Assumption and Research Methodology
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. Appendix
14.1. About Us and Services
14.2. Contact Us